Journal of Bioequivalence & Bioavailability

Bioavailability Enhancement Techniques in Modern Pharmaceutical Drug Delivery Systems

Alexander Hughes ^* Department of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada
^*Correspondence: Alexander Hughes, Department of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada, Email:

Received: 12-May-2026 , Manuscript No. JBB-26-31804; Editor assigned: 14-May-2026 , Pre QC No. JBB-26-31804 (PQ); Reviewed: 29-May-2026 , QC No. JBB-26-31804; Revised: 05-Jun-2026 , Manuscript No. JBB-26-31804 (R); Published: 12-Jun-2026 , DOI: 10.35248/0975-0851.26.18.701

Description

Bioavailability enhancement techniques occupy an important position in modern pharmaceutical development, particularly for orally administered drugs that exhibit limited aqueous solubility or poor permeability across biological membranes. The extent and rate at which an active pharmaceutical ingredient reaches systemic circulation determine its therapeutic performance, and many newly discovered drug molecules face challenges related to dissolution, stability, or intestinal absorption. To address these limitations, a variety of formulation-based, chemical, and technological approaches have been developed to improve systemic exposure and optimize therapeutic outcomes. One of the widely applied strategies involves particle size reduction. By decreasing particle size to the micro or nanoscale, the surface area available for dissolution increases significantly, leading to improved dissolution velocity. Techniques such as micronization and nanosizing have been employed to enhance the absorption of poorly soluble drugs. 

Nanosuspensions, in particular, provide a stable dispersion of drug particles in a liquid medium, improving solubility and bioavailability without altering the chemical structure of the drug. These systems are stabilized using surfactants or polymers to prevent aggregation and maintain uniform distribution.Solid dispersion systems represent another established approach for improving bioavailability. In this technique, the drug is dispersed in an inert hydrophilic carrier, often in an amorphous state, which enhances wettability and dissolution rate. Carriers such as polyethylene glycol, polyvinylpyrrolidone, and hydroxypropyl methylcellulose are commonly used. The transition from crystalline to amorphous form reduces lattice energy, making it easier for the drug to dissolve upon administration. Various methods, including solvent evaporation, melt extrusion, and spray drying, are utilized to prepare solid dispersions depending on the physicochemical properties of the drug.

Lipid-based drug delivery systems have gained attention for their ability to improve the solubility and absorption of lipophilic compounds. Self-emulsifying drug delivery systems, selfmicroemulsifying formulations, and lipid nanoparticles facilitate the formation of fine emulsions in gastrointestinal fluids, increasing surface area for absorption. These systems promote lymphatic transport and reduce first-pass metabolism, thereby enhancing systemic availability. The composition of lipid-based formulations, including oils, surfactants, and co-solvents, is carefully selected to optimize drug release and absorption characteristics. Cyclodextrin complexation is another technique used to improve solubility and stability of poorly water-soluble drugs. Cyclodextrins are cyclic oligosaccharides capable of forming inclusion complexes with hydrophobic molecules. 

This interaction enhances aqueous solubility without chemically modifying the drug. The formation of these complexes improves dissolution rate and can also protect the drug from degradation in the gastrointestinal environment. Different types of cyclodextrins, including alpha, beta, and gamma derivatives, are selected based on cavity size and drug compatibility.Salt formation is a conventional yet effective method for enhancing bioavailability. By converting a drug into its salt form, solubility and dissolution rate can be significantly improved. The choice of counterion influences physicochemical properties such as stability, hygroscopicity, and dissolution behavior. This approach is particularly suitable for weak acids and bases, where ionization can be exploited to improve aqueous solubility under physiological conditions. Prodrug design offers a chemical modification strategy to improve pharmacokinetic properties.

.In this approach, an inactive or less active derivative of the drug is synthesized, which undergoes enzymatic or chemical conversion in vivo to release the active molecule. Prodrugs can be designed to enhance solubility, permeability, or stability, depending on the intended therapeutic goal. This strategy also allows for site-specific activation, reducing systemic exposure during circulation.Nanocarrier systems, including liposomes, polymeric nanoparticles, and dendrimers, provide advanced platforms for bioavailability enhancement. These carriers protect the drug from degradation, improve solubility, and facilitate transport across biological barriers. Surface modification of nanoparticles with hydrophilic polymers can prolong circulation time, while ligand attachment enables targeted delivery. Controlled release properties of nanocarriers contribute to sustained therapeutic levels and improved dosing efficiency.Permeation enhancers are used to increase drug transport across biological membranes, particularly for drugs with poor permeability. These agents transiently modify membrane structure or function to facilitate drug passage. Fatty acids, bile salts, and certain surfactants are commonly used as permeation enhancers in oral and transdermal formulations. Their use is carefully controlled to ensure reversibility and minimize tissue irritation.

In Conclusion, Bioavailability enhancement techniques provide a diverse set of tools to improve the therapeutic performance of drug molecules with limited absorption characteristics. Through approaches such as particle size reduction, solid dispersions, lipid-based systems, cyclodextrin complexation, prodrug design, and nanocarrier technologies, formulation scientists are able to address solubility and permeability challenges. Continued progress in material science and manufacturing technologies is expanding the range of available strategies. These developments support the creation of more efficient drug delivery systems and contribute to improved therapeutic consistency across a broad spectrum of pharmaceutical products.